TR201005325A2 - Atorvastatin ve aspirin içeren farmasötik formülasyonlar - Google Patents
Atorvastatin ve aspirin içeren farmasötik formülasyonlarInfo
- Publication number
- TR201005325A2 TR201005325A2 TR2010/05325A TR201005325A TR201005325A2 TR 201005325 A2 TR201005325 A2 TR 201005325A2 TR 2010/05325 A TR2010/05325 A TR 2010/05325A TR 201005325 A TR201005325 A TR 201005325A TR 201005325 A2 TR201005325 A2 TR 201005325A2
- Authority
- TR
- Turkey
- Prior art keywords
- aspirin
- pharmaceutical formulations
- formulations containing
- containing atorvastatin
- atorvastatin
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 title abstract 2
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
- 229960005370 atorvastatin Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/05325A TR201005325A2 (tr) | 2010-06-30 | 2010-06-30 | Atorvastatin ve aspirin içeren farmasötik formülasyonlar |
| EP11764886.5A EP2588103A1 (fr) | 2010-06-30 | 2011-06-29 | Combinaison d'atorvastatine et d'aspirine destinée à être utilisée dans le traitement de maladies cardiovasculaires |
| PCT/TR2011/000161 WO2012002919A1 (fr) | 2010-06-30 | 2011-06-29 | Formulations pharmaceutiques comprenant de l'atorvastatine et de l'aspirine |
| EP11746335.6A EP2588102A1 (fr) | 2010-06-30 | 2011-06-29 | Nouvelles formes pharmaceutiques pour le traitement de maladies cardiovasculaires |
| PCT/TR2011/000163 WO2012002920A1 (fr) | 2010-06-30 | 2011-06-29 | Nouvelles formes pharmaceutiques pour le traitement de maladies cardiovasculaires |
| PCT/TR2011/000162 WO2012011882A1 (fr) | 2010-06-30 | 2011-06-29 | Combinaison d'atorvastatine et d'aspirine destinée à être utilisée dans le traitement de maladies cardiovasculaires |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/05325A TR201005325A2 (tr) | 2010-06-30 | 2010-06-30 | Atorvastatin ve aspirin içeren farmasötik formülasyonlar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201005325A2 true TR201005325A2 (tr) | 2012-01-23 |
Family
ID=44487203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/05325A TR201005325A2 (tr) | 2010-06-30 | 2010-06-30 | Atorvastatin ve aspirin içeren farmasötik formülasyonlar |
Country Status (3)
| Country | Link |
|---|---|
| EP (2) | EP2588103A1 (fr) |
| TR (1) | TR201005325A2 (fr) |
| WO (3) | WO2012002919A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013155430A1 (fr) * | 2012-04-13 | 2013-10-17 | Banner Pharmacaps, Inc. | Capsules molles élastiques contenant des comprimés et remplies de liquides ou de semi-solides et procédés pour leur fabrication |
| KR101378973B1 (ko) * | 2012-04-13 | 2014-03-28 | 한미약품 주식회사 | 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법 |
| ES2524645B1 (es) * | 2013-06-06 | 2015-12-02 | Ferrer Internacional, S.A. | Formulación oral para el tratamiento de enfermedades cardiovasculares |
| RU2536275C1 (ru) * | 2013-08-06 | 2014-12-20 | Строяковский Валентин Меерович | Антигипоксическое и гиполидемическое фармацевтическое средство, улучшающее коронарный и мозговой кровоток |
| KR20180073597A (ko) * | 2015-11-06 | 2018-07-02 | 젬파이어 세러퓨틱스 인코포레이티드 | 혼합 이상지질혈증의 치료 |
| TW201906599A (zh) * | 2017-05-11 | 2019-02-16 | 美商珍費爾醫療公司 | 吉卡賓組成物及其使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
| US6669955B2 (en) | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| US20040115265A1 (en) | 2002-12-11 | 2004-06-17 | Loutfy Benkerrour | Multilayered tablet containing pravastatin and aspirin and method |
| WO2004080488A2 (fr) * | 2003-03-10 | 2004-09-23 | Bayer Healthcare Ag | Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires |
| CN1802178A (zh) * | 2003-06-06 | 2006-07-12 | 武田药品工业株式会社 | 固体制剂 |
| WO2006000052A1 (fr) * | 2004-06-28 | 2006-01-05 | Howard J Smith & Associates Pty Ltd | Composition et procede pour le traitement et la prevention de l'atherosclerose |
| KR100955669B1 (ko) * | 2007-08-13 | 2010-05-06 | 한올바이오파마주식회사 | ＨＭＧＣｏＡ 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법 |
| WO2009118359A2 (fr) * | 2008-03-28 | 2009-10-01 | Ferrer Internacional S.A. | Capsule pour la prévention de maladies cardiovasculaires |
| CA2754134C (fr) * | 2009-02-11 | 2018-09-18 | Cadila Pharmaceuticals Ltd. | Composition pharmaceutique stable pour l'atherosclerose |
| KR101193493B1 (ko) * | 2010-02-02 | 2012-10-22 | 한미사이언스 주식회사 | 소수성 첨가제가 함유된 분리막으로 코팅된 아스피린 및 ＨＭＧ?ＣｏＡ 환원효소 억제제를 포함하는 복합제제 |
-
2010
- 2010-06-30 TR TR2010/05325A patent/TR201005325A2/xx unknown
-
2011
- 2011-06-29 EP EP11764886.5A patent/EP2588103A1/fr not_active Withdrawn
- 2011-06-29 WO PCT/TR2011/000161 patent/WO2012002919A1/fr not_active Ceased
- 2011-06-29 WO PCT/TR2011/000162 patent/WO2012011882A1/fr not_active Ceased
- 2011-06-29 EP EP11746335.6A patent/EP2588102A1/fr not_active Withdrawn
- 2011-06-29 WO PCT/TR2011/000163 patent/WO2012002920A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012002920A1 (fr) | 2012-01-05 |
| EP2588102A1 (fr) | 2013-05-08 |
| WO2012002919A1 (fr) | 2012-01-05 |
| WO2012011882A1 (fr) | 2012-01-26 |
| EP2588103A1 (fr) | 2013-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014028600A3 (fr) | Composés 3-aminocycloalkyl utilisés en tant qu'inhibiteurs de rorgammat et utilisations de ceux-ci | |
| TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
| PE20121617A1 (es) | Derivados de oxazina como inhibidores de bace | |
| WO2014028591A3 (fr) | Composés indazole et indole n-alkylés utilisés en tant qu'inhibiteurs de rorgammat et utilisations de ceux-ci | |
| EA201170434A1 (ru) | Макроциклические ингибиторы сериновых протеаз гепатита с | |
| BR112012007747A2 (pt) | Compostos heterocíclicos úteis como inibidores de pdk1, sua composição farmacêutica e seus usos | |
| IN2014MN02598A (fr) | ||
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| EA201300669A1 (ru) | Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение | |
| EP2415763A4 (fr) | Composition pharmaceutique pour la prévention ou le traitement du glaucome | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| PH12013501800A1 (en) | Tricyclic gyrase inhibitors | |
| WO2011093826A3 (fr) | Formulations effervescentes comprenant du céfaclor et de l'acide clavulanique comme principes actifs | |
| EA201500365A1 (ru) | Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака | |
| TN2015000084A1 (fr) | Pyridinones bicycliques nouvelles | |
| IN2014CN03597A (fr) | ||
| EA201170356A1 (ru) | Полиморфные и аморфные формы лакозамида и аморфные композиции | |
| MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
| EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения | |
| TR201005325A2 (tr) | Atorvastatin ve aspirin içeren farmasötik formülasyonlar | |
| EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
| CU24163B1 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
| IT1397838B1 (it) | Composizione per la cura delle piante | |
| PH12015502706B1 (en) | Oral formulation for the treatment of cardiovascular diseases | |
| HK1216721A1 (zh) | 治疗肝脏疾病或病状的用途和方法 |